Nano Labs Ltd. Files 6-K Report

Ticker: NA · Form: 6-K · Filed: Sep 17, 2025 · CIK: 1872302

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, reporting

TL;DR

Nano Labs Ltd. filed a 6-K on 9/17/25 for the period ending 6/30/25, incorporating exhibits 99.1 & 99.2.

AI Summary

Nano Labs Ltd. filed a Form 6-K on September 17, 2025, reporting for the period ending June 30, 2025. The filing incorporates by reference exhibits 99.1 and 99.2, which are expected to contain further details about the company's operations or financial status. The company is incorporated in China and its principal executive offices are located in Hangzhou.

Why It Matters

This filing provides an update on Nano Labs Ltd.'s reporting status, which is crucial for investors to stay informed about the company's ongoing activities and financial health.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer and does not appear to contain significant new financial information or material events.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically to provide information that the issuer makes or is required to make public in its home country.

What period does this Form 6-K cover?

This Form 6-K is filed for the month of September 2025 and reports for the period ended June 30, 2025.

What are the principal executive offices of Nano Labs Ltd.?

The principal executive offices of Nano Labs Ltd. are located at China Yuangu Hanggang Technology Building 509 Qianjiang Road, Shangcheng District, Hangzhou, Zhejiang, 310000, People's Republic of China.

What exhibits are incorporated by reference into this filing?

Exhibits 99.1 and 99.2 are incorporated by reference into this Form 6-K.

Does Nano Labs Ltd. file annual reports under Form 20-F or 40-F?

Nano Labs Ltd. indicates that it files annual reports under cover of Form 20-F.

Filing Stats: 353 words · 1 min read · ~1 pages · Grade level 11.5 · Accepted 2025-09-17 08:23:54

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Nano Labs Ltd Date: September 17, 2025 By: /s/ Jianping Kong Name: Jianping Kong Title: Chairman and Chief Executive Officer 2 EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Unaudited Consolidated Financial Statements as of December 31, 2024 and June 30, 2025 and for the six months ended June 30, 2024 and 202 5 Exhibit 99.2

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing